Alcami carolinas corporation:1360236 [26-000076]
Active Purchase Order Awarded Last action
- Contract number
- 75N92026P00018
- Awardee
-
Alcami Carolinas Corporation UEI D2DHUF4NTK23
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $60,005
Award facts
- Opportunity
-
- Stability Testing for ManNAc Drug Product produced Solicitation · 75N92026Q00002 · Posted Nov 18, 2025
- Contract value 100% obligated
- $60,005.00 Current and potential, with all options
- Completion date 91% complete
- Current and potential, with all options
- Funding agency
- National Human Genome Research Institute National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541380 Testing Laboratories and Services
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 2 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
About this award
Alcami Carolinas Corporation was awarded a $60,005 firm fixed-price purchase order by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health under the Department of Health and Human Services. The contract, awarded on December 10, 2025, with an ultimate completion date of December 9, 2026, calls for stability testing services on ManNAc drug product to support regulatory compliance and product development objectives. The work will be performed in Bethesda, Maryland, and no set-aside designation was used in the competitive process.
The underlying solicitation, posted on November 18, 2025 with a November 25, 2025 proposal deadline, sought qualified testing laboratory services falling under the Testing Laboratories and Services NAICS category. Alcami Carolinas Corporation, operating as Alcami Corporation, was selected based on technical qualifications, laboratory capabilities, experience with pharmaceutical stability testing, and compliance with relevant regulatory standards. This procurement supports NHGRI's broader mission in genomics research and development by ensuring the stability and regulatory viability of pharmaceutical products in development.
Quick answers
Who was awarded contract 75N92026P00018?
75N92026P00018 was awarded to Alcami Carolinas Corporation by National Heart Lung and Blood Institute (National Institutes of Health) on December 10, 2025.
How much is contract 75N92026P00018 worth?
The government has obligated $60,005 on 75N92026P00018.
Which agency awarded contract 75N92026P00018?
National Heart Lung and Blood Institute (National Institutes of Health) awarded 75N92026P00018, with funding from National Human Genome Research Institute (National Institutes of Health).
Was contract 75N92026P00018 competed?
The extent of competition for 75N92026P00018 was competed under sap. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award